operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-17Feb2022 Full

Page 95

AstraZeneca Vaccine administration and observation This section outlines the administration of the AstraZeneca vaccine. Please read this section with the Pfizer section above. For more information see IMAC guidelines found on the IMAC website and the Immunisation handbook Section 2.2 for the correct vaccine administration process.

Table 26.1 – pre-vaccination greeting and verify identity Step

Action On arrival at the vaccination site, the vaccinator/site administrator will greet the consumer and ask whether they have any COVID-19 symptoms as per standard site practices*. Please note:

Greet consumer, conduct COVID-19 health check

• People who have symptoms of COVID-19 should be advised to stay at home and get a test. They can be vaccinated once they have a negative test result and symptoms are mild only. • People who have been to a current location of interest according to the Ministry’s website, are advised to go home and follow the specific advice for the site of interest they attended. • People who are significantly unwell are advised to wait until they are better before getting the vaccine; however, note that mild symptoms are not a contra-indication. People in this situation are advised to discuss their symptoms with their GP or vaccine provider. • People who have been advised to self-isolate, stay at home or are waiting on a test result, should have their appointment deferred. • Please see the Vaccination Site screening questions below for questions related to clinical assessment. The vaccinator/site administrator will also verify the consumer’s identity using name, DOB, address, and locate their record in CIR. Check the consumer’s DOB and confirm age. If the consumer is under the age of 18 do not vaccinate with AstraZeneca.

Verify consumer’s identity

• If the consumer has presented for their second AstraZeneca vaccination and their first dose was given less than 28 days ago do not vaccinate. Note: Photo ID is not required to confirm the consumer’s identity.

*Especially those people who meet the New Zealand/Aotearoa Government ‘higher index of suspicion’ (HIS) criteria. Version 33.0 Page 95


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Document version control

2min
pages 155-156

Appendix K: Vaccination practice variation according to the COVID-19 Protection Framework changes

5min
pages 153-154

Appendix J: Risk mitigations for vaccination sites

2min
page 152

Appendix E: CVIP logistics overview/cheat sheets

4min
pages 140-141

Appendix D: Logistics and inventory management

1min
page 139

Appendix G: Vaccination site screening questions

1min
page 143

Variations

1min
page 126

Incidents

6min
pages 121-125

National Immunisation Booking System

11min
pages 115-120

Affected persons under the Vaccinations Order

4min
pages 112-114

COVID-19 Trial Vaccinations

1min
page 111

Home vaccinations

2min
pages 109-110

Mobile vaccination team

1min
page 108

Vaccination in Hospital

1min
page 107

Vaccination and Surveillance Testing

1min
page 106

Vaccination in high-risk or screened ‘positive’ consumers

4min
pages 102-104

Third primary dose for severely immunocompromised

1min
page 105

Section E: Additional programme guidance, variations and incidents

1min
page 101

AstraZeneca Vaccine administration and observation

7min
pages 95-100

AstraZeneca Preparation of doses

2min
pages 93-94

AstraZeneca Operational phase

1min
page 92

Booking and scheduling

1min
page 91

Section D: AstraZeneca COVID-19 Vaccine

1min
page 90

Paediatric Pfizer Vaccine administration and observation

8min
pages 85-89

Paediatric Pfizer Preparation of doses

3min
pages 82-84

Pfizer Vaccine administration and observation

12min
pages 69-77

Pfizer Preparation of doses

4min
pages 66-68

Pfizer Operational phase

2min
pages 63-64

Protecting security and privacy

1min
page 62

Vaccinating consumers aged 12 to 15 years

1min
page 65

Booking and scheduling

2min
pages 60-61

Becoming a COVID-19 Vaccination site

1min
page 58

Site readiness and closure

1min
page 57

Disposal of consumables, vaccine, and vaccine packaging

2min
pages 55-56

COVID-19 Immunisation Register

3min
pages 27-29

Logistics

1min
page 30

Vaccine storage and handling

7min
pages 37-42

Infection prevention and control (IPC

2min
pages 25-26

Preparing the vaccination workforce

7min
pages 20-24

Equipment ordering and demand planning

7min
pages 31-36

Site considerations

7min
pages 16-19

Section A: Ready to vaccinate

1min
page 13
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-17Feb2022 Full by WBOP PHO - Issuu